ERBB2 and breast neoplasm: All breast tumor diagnosis begins with classification based on the detection of estrogen (ER), progesterone (PgR), and human epidermal growth factor-2 (HER2) receptors by immunohistochemistry (IHC) combined with molecular and gene expression analyses [3].